In Depth 21 Aug 2024 The promise of antisense oligonucleotides in precision medicine Find out all about antisense oligonucleotides, which have gained a lot of popularity in recent years and could treat numerous diseases. August 21, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 9 Aug 2024 The therapeutic potential of circular RNA: Could it soon trump mRNA technology? Find out about circular RNA, an emerging technology that could hold a lot of promise for next-generation vaccines and gene therapies. August 9, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 6 Aug 2024 The biggest private biotech investments in July 2024 The companies Cardurion Pharmaceuticals, Beacon Therapeutics, and Third Arc Bio bagged the biggest private biotech investments in July 2024. August 6, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 30 Jul 2024 Why is the immunology and inflammation market suddenly attracting a wave of investment? Discover why the immunology and inflammation market has recently been attracting a major wave of investment. July 30, 2024 - 13 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 24 Jul 2024 Danuglipron: Is Pfizer’s oral weight loss pill a contender in the obesity market? Find out more about Pfizer’s GLP-1 candidate danuglipron, as the company aims to compete in the obesity market. July 24, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Expert Advice 19 Jul 2024 The ABC of biotech partnerships Discover eight different types of biotech partnerships, including what each one entails and its advantages and disadvantages. July 19, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 18 Jul 2024 Lenacapavir: Can Gilead’s drug end the HIV pandemic? Discover more about Gilead’s lenacapavir, which recently demonstrated 100% efficacy for HIV prevention in a phase 3 trial. July 18, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 15 Jul 2024 Fighting EEHV in elephants: How mRNA vaccines can offer hope against viruses affecting animals Discover how a new mRNA vaccine could help to tackle EEHV in elephants, which is a number one killer of Asian elephant calves. July 15, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 9 Jul 2024 The 7 biotech companies in Portugal you should know about in 2024 We take a look at seven biotech companies in Portugal, which is home to a rich biotech ecosystem that is rapidly growing. July 9, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 8 Jul 2024 Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR Find out how the recent discovery of a molecular oddity found in bacteria has led to a new gene editing technique. July 8, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 4 Jul 2024 The biggest private biotech investments in June 2024 The companies Formation Bio, Isotopen Technologien München, and Marea Therapeutics bagged the biggest private biotech investments in June 2024. July 4, 2024 - 2 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 1 Jul 2024 Special Olympics: How is biotechnology revolutionizing sports performance worldwide? Find out about biotechnology’s impact on sports performance and recovery, from genetic profiling, stem cells, and wearable technologies. July 1, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email